Process

Congress Needs Its Own Regulatory Review Office

Congress Needs Its Own Regulatory Review Office

OIRA oversight of regulation is necessary, but not sufficient.

Expand Centralized Regulatory Review to Independent Agencies

Expand Centralized Regulatory Review to Independent Agencies

Congress should require independent regulatory commissions to perform cost-benefit analyses

New Recommendations for Valuing Mortality Risk Reductions

New Recommendations for Valuing Mortality Risk Reductions

EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.

The REINS Act: A Constitutional Means to Control Delegation

The REINS Act: A Constitutional Means to Control Delegation

The proposed legislation would give Congress authority over a limited set of major regulations.

Senate Committee Continues Review of Regulatory Reform Bills

Senate Committee Continues Review of Regulatory Reform Bills

Two former OIRA Administrators testify at hearing.

The Dangers of Indicators

The Dangers of Indicators

Increased reliance on indicators can mask an institution’s non-quantifiable policies, Galit A. Sarfaty argues.

HHS Releases Progress Report on Open Government

HHS Releases Progress Report on Open Government

The agency details its plans to enhance transparency, public collaboration.

Rulemakings at the Fed, CFPB Need White House Supervision

Rulemakings at the Fed, CFPB Need White House Supervision

After Dodd-Frank, financial regulations of independent agencies should be subject to OIRA review.

Agencies Should Provide Enhanced Procedural Protections in Aggregate Settlements

Agencies Should Provide Enhanced Procedural Protections in Aggregate Settlements

Agencies fail to provide necessary fairness when they compensate large groups of people.

Obama Directs Independent Regulatory Agencies

Obama Directs Independent Regulatory Agencies

Executive order contains strongly worded regulatory reform guidelines.

Prospects for Regulatory Reform

Prospects for Regulatory Reform

Congress should use a rare political moment to improve the U.S. regulatory process.